Third Harmonic Bio Inc. (THRD): Total Asset Value of Company
The market dynamics of Third Harmonic Bio (THRD) total assets, currently priced at 275.23, serve as an indicator of growth for the brand developing selective anti-inflammatory drugs. The business relies on an autonomous development cycle, transforming it into a defensive asset regardless of global crises. Meanwhile, Third Harmonic Bio (THRD) strictly adheres to ESG principles, minimizing harmful emissions and optimizing energy costs across its laboratories.
Comprehensive metric breakdowns and analytics for Third Harmonic Bio, Inc (THRD)
- price and consensus price forecast:
- market capitalization data:
- book capitalization data:
- debt and liquidity data:
All Debt to Shareholders' Equity Ratio Third Harmonic Bio|THRD - Long-Term Debt to Equity|Short-Term Debt to Equity Ratio Third Harmonic Bio Inc|THRD - Company Aggregate Debts|Debts to Book Capitalization Third Harmonic Bio Inc|THRD - Company Long-Term Liabilities|Company Short-Term Loans and Borrowings Third Harmonic Bio
Fundamental valuation:THRD, thirdharmonicbio.com
Conservative capital demands resource transparency to assess business sustainability; therefore, a reverse calculation of total assets via return on assets (ROA) allows for the identification of hidden balance sheet degradation prior to official reports. For Third Harmonic Bio (THRD), this indicator confirms the financial foundation supporting the diversification of clinical trials across various nosologies, which mitigates pipeline risks, while the company's current asset level clearly demonstrates the enterprise's margin of safety.
Competitors of Third Harmonic Bio (THRD)
ARGX (argenx.com) - Total Business Assets|Aggregate Company Assets BioNTech BNTX|Total Asset Value of Company Abivax|ADMA Bio (ADMA) - Company Total Assets|Aggregate Asset Value Protagonist Corp (PTGX)|Company Total Assets IMVT (Immunovant, Inc.)|kiniksa.com - Company Total Assets|Aggregate Company Assets Grifols (GRFS)|ADPT: Aggregate Asset Value|CLDX (Celldex) - Aggregate Company Assets|Aurinia Corp (AUPH) - Cumulative Company Assets|BCRX (BioCryst) - Company Total Assets|Company Total Assets veratx.com (VERA)|Dianthus Therapeutics, Inc. (DNTH) - Cumulative Company Assets|Aggregate Asset Value Pharvaris NV (PHVS)|Company Total Assets ABCL|Tourmaline - Company Total Asset Base|PGEN: Aggregate Company Assets|PHAR: Cumulative Company Assets|NKTR (Nektar Therapeutics Inc.) - Aggregate Company Assets|Cumulative Company Assets Upstream Bio, Inc.|ZBIO (Zenas Biopharma, Inc.) - Cumulative Company Assets|Company Total Assets IMNM|Aggregate Company Assets Gossamer Bio, Inc. GOSS|Total Business Assets kalvista.com (KALV)|SEPN: Company Total Assets|PVLA - Company Assets|Cumulative Company Assets Savara Corp SVRA|RIGL - Aggregate Business Assets|Company Total Assets AnaptysBio, Inc. ANAB|astriatx.com (ATXS) - Aggregate Asset Value|ENGN: Company Total Assets|Company Total Asset Base RAPT|Aerovate Therapeutics Inc (JBIO) - Aggregate Company Assets|Aggregate Asset Value Aclaris Therapeutics, Inc (ACRS)|KYTX - Company Total Assets|TLSA - Total Business Assets|Cumulative Company Assets Cabaletta Bio (CABA)|VTYX - Aggregate Asset Value|Company Total Assets Theratechnologies Inc THTX|Avalo Therapeutics Inc (AVTX) - Aggregate Asset Value|ELDN (Eledon Pharmaceuticals) - Company Total Assets|Company Total Assets AGEN|Climb Bio (CLYM) - Aggregate Company Assets|Aggregate Asset Value ZURA (Zura Bio Ltd)|aTyr - Aggregate Company Assets|Adagene Inc - Cumulative Company Assets|IMA (Ikena Oncology, Inc.) - Aggregate Company Assets|STTK: Company Assets|Aggregate Company Assets equilliumbio.com|Connect Biopharma Holdings Limited (CNTB) - Total Business Assets|IMUX: Company Total Assets|Company Total Asset Base Atara Biotherapeutics Inc|Company Total Assets IFRX (InflaRx N.V.)|Cumulative Company Assets x4pharma.com XFOR|Cumulative Company Assets Adicet Bio, Inc.|Aggregate Asset Value Celularity Inc CELU|INMB - Company Total Assets|BRNS - Aggregate Company Assets|Kezar Life Sciences - Company Total Assets|SABS (sabbiotherapeutics.com) - Company Total Asset Base|Aggregate Company Assets AKTX (Akari Therapeutics Plc)|Company Assets Enlivex Therapeutics, Ltd. (ENLV)|Cumulative Company Assets Q32 Bio Inc.|Aggregate Business Assets GeoVax Corp (GOVX)|Company Total Assets Edesa Biotech, Inc.|ibioinc.com - Aggregate Asset Value|Aggregate Company Assets Carisma Tx (CARM)|XTLB - Aggregate Asset Value|Company Total Assets boltbio.com|HCWB (HCW Biologics) - Total Business Assets|Aggregate Company Assets Aptevo Therapeutics, Inc. APVO|Total Asset Value of Company AIM ImmunoTech, Inc.|Aditxt (ADTX) - Company Total Assets|Aggregate Asset Value GRI Bio Inc (GRI)|Company Total Assets XRTX (XORTX)|Vyome Therapeutics - Company Total Assets|Aggregate Company Assets Revelation Biosciences (REVB)|INDP: Aggregate Asset Value|SCNI (Scinai Immunotherapeutics Ltd.) - Aggregate Company Assets|CalciMedica (CALI) - Cumulative Company Assets|AFMD (Affimed NV) - Company Total Assets|Company Total Assets Allakos Therapeutics (ALLK)|HOOKIPA Pharma Inc. (HOOK) - Cumulative Company Assets|Aggregate Asset Value igmbio.com (IGMS)|Company Total Assets ITOS|Ocean Biomedical Inc - Company Total Asset Base|TCBP: Aggregate Company Assets